DK0785933T3 - Indolderivater som 5HT1-lignende agonister - Google Patents
Indolderivater som 5HT1-lignende agonisterInfo
- Publication number
- DK0785933T3 DK0785933T3 DK95934124.9T DK95934124T DK0785933T3 DK 0785933 T3 DK0785933 T3 DK 0785933T3 DK 95934124 T DK95934124 T DK 95934124T DK 0785933 T3 DK0785933 T3 DK 0785933T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- date apr
- sec
- alkyl
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Toxicology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9420503A GB9420503D0 (en) | 1994-10-11 | 1994-10-11 | Therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0785933T3 true DK0785933T3 (da) | 1998-05-11 |
Family
ID=10762688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95934124.9T DK0785933T3 (da) | 1994-10-11 | 1995-09-29 | Indolderivater som 5HT1-lignende agonister |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5770611A (fi) |
| EP (1) | EP0785933B1 (fi) |
| JP (1) | JP2902484B2 (fi) |
| AT (1) | ATE163934T1 (fi) |
| DE (1) | DE69501791T2 (fi) |
| DK (1) | DK0785933T3 (fi) |
| ES (1) | ES2113213T3 (fi) |
| FI (1) | FI113863B (fi) |
| GB (1) | GB9420503D0 (fi) |
| GR (1) | GR3026532T3 (fi) |
| WO (1) | WO1996011195A1 (fi) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9420529D0 (en) | 1994-10-12 | 1994-11-30 | Pfizer Ltd | Indoles |
| DE69824632T2 (de) | 1997-11-12 | 2005-06-09 | Mitsubishi Chemical Corp. | Purinderivate und medikamente, welche dieselben als aktiven bestandteil enthalten |
| CA2334002A1 (en) | 1998-06-03 | 1999-12-09 | Mark H. Norman | N-linked sulphonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres |
| WO2000068231A1 (fr) | 1999-05-11 | 2000-11-16 | Mitsubishi Chemical Corporation | Dihydrate derive de purine, medicaments le contenant comme principe actif et intermediaire utilise dans sa preparation |
| WO2011158149A1 (en) | 2010-06-18 | 2011-12-22 | Pfizer Inc. | 2-(3,5-disubstitutedphenyl)pyrimidin-4(3h)-one derivatives |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5607951A (en) * | 1990-10-15 | 1997-03-04 | Pfizer Inc | Indole derivatives |
| US5578612A (en) * | 1990-10-15 | 1996-11-26 | Pfizer Inc. | Indole derivatives |
| US5545644A (en) * | 1990-10-15 | 1996-08-13 | Pfizer Inc. | Indole derivatives |
| US5559246A (en) * | 1990-10-15 | 1996-09-24 | Pfizer Inc. | Indole derivatives |
| US5559129A (en) * | 1990-10-15 | 1996-09-24 | Pfizer Inc | Indole derivatives |
| KR0184911B1 (ko) * | 1991-11-25 | 1999-05-01 | 알렌 제이. 스피겔 | 인돌유도체 |
| US5409941A (en) * | 1992-02-03 | 1995-04-25 | Pfizer Inc. | 5-heteroyl indole derivatives |
| TW288010B (fi) * | 1992-03-05 | 1996-10-11 | Pfizer | |
| NZ251047A (en) * | 1992-04-10 | 1996-09-25 | Pfizer | Acylaminoindole derivatives and medicaments |
| GB9207930D0 (en) * | 1992-04-10 | 1992-05-27 | Pfizer Ltd | Indoles |
| GB9208161D0 (en) * | 1992-04-14 | 1992-05-27 | Pfizer Ltd | Indoles |
| PL311204A1 (en) * | 1993-04-22 | 1996-02-05 | Pfizer Res & Dev | Indole derivatives as antagonists of 5-ht-like receptors for use in hemicrania |
| GB9424471D0 (en) * | 1994-12-03 | 1995-01-18 | Pfizer Ltd | Treatment of emesis |
-
1994
- 1994-10-11 GB GB9420503A patent/GB9420503D0/en active Pending
-
1995
- 1995-09-29 DK DK95934124.9T patent/DK0785933T3/da active
- 1995-09-29 EP EP95934124A patent/EP0785933B1/en not_active Expired - Lifetime
- 1995-09-29 ES ES95934124T patent/ES2113213T3/es not_active Expired - Lifetime
- 1995-09-29 WO PCT/EP1995/003884 patent/WO1996011195A1/en active IP Right Grant
- 1995-09-29 JP JP8512312A patent/JP2902484B2/ja not_active Expired - Fee Related
- 1995-09-29 DE DE69501791T patent/DE69501791T2/de not_active Expired - Fee Related
- 1995-09-29 AT AT95934124T patent/ATE163934T1/de not_active IP Right Cessation
- 1995-09-29 US US08/809,600 patent/US5770611A/en not_active Expired - Fee Related
-
1997
- 1997-04-10 FI FI971492A patent/FI113863B/fi active
-
1998
- 1998-04-03 GR GR980400716T patent/GR3026532T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US5770611A (en) | 1998-06-23 |
| DE69501791T2 (de) | 1998-07-02 |
| GB9420503D0 (en) | 1994-11-23 |
| JP2902484B2 (ja) | 1999-06-07 |
| GR3026532T3 (en) | 1998-07-31 |
| FI971492A0 (fi) | 1997-04-10 |
| DE69501791D1 (de) | 1998-04-16 |
| FI971492A (fi) | 1997-04-10 |
| FI113863B (fi) | 2004-06-30 |
| ATE163934T1 (de) | 1998-03-15 |
| MX9702643A (es) | 1997-07-31 |
| EP0785933A1 (en) | 1997-07-30 |
| JPH09512034A (ja) | 1997-12-02 |
| ES2113213T3 (es) | 1998-04-16 |
| EP0785933B1 (en) | 1998-03-11 |
| WO1996011195A1 (en) | 1996-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2157397A1 (en) | Indole derivatives as 5-ht1-like agonists for use in migraine | |
| NO20023995D0 (no) | 2-okso-1-pyrrolidinderivater, fremgangsmåte for fremstilling og anvendelse av disse | |
| EP0354777A3 (en) | 3-(4-piperidine)-5-(2-sulfonylaminoethyl) indole derivatives | |
| ATE92057T1 (de) | Indol-derivate. | |
| PT729455E (pt) | Arilpiperazinas derivadas de indol como ligados para os receptores 5ht1-like, 5ht1b e 5ht1d | |
| ATE17249T1 (de) | 9-(2-(3-indolyl)aethyl)-1-oxa-4,9diazaspiro(5.5)undecan-3-one. | |
| IT1171880B (it) | Derivati di 2-ammino-3-acilammino-6-benzilammino-piridina aventi azione antiepilettica e procedimento per la loro produzione | |
| NO893480L (no) | Fremgangsmaate for fremstilling av disubstituerte benzylaminer. | |
| FI944727A0 (fi) | Indolijohdannaisia 5-HT1:n kaltaisina agonisteina | |
| DK0785933T3 (da) | Indolderivater som 5HT1-lignende agonister | |
| FI943931A0 (fi) | Indolijohdannaisia steroidi-5alfa-reduktaasin inhibiittoreina | |
| DK0871626T3 (da) | Triazoloner som apolipoprotein-B syntheseinhibitorer | |
| CA2202348A1 (en) | Indole derivatives as 5ht1-like agonists | |
| ES2128572T3 (es) | Utilizacion de los derivados de cefem como agentes antimetastaticos. | |
| NO985685L (no) | Dibenzo-oksazepin- og -dioksazepin-derivater og deres anvendelse som anti-tumormidler | |
| NO961719D0 (no) | 3-aryl-4-alkyl og 4,5-dialkyl-4H-1,2,4-triazoler som er anvendbare som hukommelsesforsterkere | |
| DE69806411D1 (de) | Neue antiarrythmische verbindungen |